Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.

<h4>Aims</h4>To evaluate the impact of small-for-size grafts (SFSG) in adult-to-adult living donor liver transplantation (AALDLT) on outcomes of recipients with different model for end-stage liver disease (MELD) score in a single liver transplant center.<h4>Materials and methods<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: HongYu Li, Bo Li, YongGang Wei, LvNan Yan, TianFu Wen, MingQing Xu, WenTao Wang, JiaYin Yang
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f310d2aabcb845a1a14ccd9b3b9687ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f310d2aabcb845a1a14ccd9b3b9687ad
record_format dspace
spelling oai:doaj.org-article:f310d2aabcb845a1a14ccd9b3b9687ad2021-11-18T08:55:45ZOutcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.1932-620310.1371/journal.pone.0074081https://doaj.org/article/f310d2aabcb845a1a14ccd9b3b9687ad2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24040171/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Aims</h4>To evaluate the impact of small-for-size grafts (SFSG) in adult-to-adult living donor liver transplantation (AALDLT) on outcomes of recipients with different model for end-stage liver disease (MELD) score in a single liver transplant center.<h4>Materials and methods</h4>Clinical data of 118 patients underwent right-lobe AALDLT from January 2004 to December 2011 were retrospectively analyzed, Patients were divided into Group L (MELD score ≤ 25) and Group H (MELD score > 25) according to MELD score. The patients were further stratified into Group LS (MELD score ≤ 25, GBWR < 0.8%), Group LN (MELD score ≤ 25, GBWR ≥ 0.8%), Group HS (MELD score > 25, GBWR < 0.8%), and Group HN (MELD score > 25, GBWR ≥ 0.8%) to investigate the impact of graft size on recipients' complications and outcomes. Pre-operative characteristics, post-operative complications graded by the Clavien score and patient survival were analyzed.<h4>Results</h4>MELD scores between the two groups were significant different (12.4 ± 4.9 vs 34.5 ± 7.5, P = 0.026). There was no significant difference in preoperative demographic data as well as postoperative liver function. Complication rate, length of ICU and hospital stay, graft loss, and mortality were similar in both groups. The 1- and 3- year survival were similar between group H and group L. When recipients were further stratified into group LS, LN, HS, and HN, no significant difference was found among groups in 1- and 3- year survival rate. In multivariate analysis, HCC was not a predictor for long term survival.<h4>Conclusion</h4>Our single institution experience demonstrates that it is safe to use SFSGs in high pre-MELD score recipients with the improvement of intensive care and the selection of listing criteria.HongYu LiBo LiYongGang WeiLvNan YanTianFu WenMingQing XuWenTao WangJiaYin YangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74081 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
HongYu Li
Bo Li
YongGang Wei
LvNan Yan
TianFu Wen
MingQing Xu
WenTao Wang
JiaYin Yang
Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
description <h4>Aims</h4>To evaluate the impact of small-for-size grafts (SFSG) in adult-to-adult living donor liver transplantation (AALDLT) on outcomes of recipients with different model for end-stage liver disease (MELD) score in a single liver transplant center.<h4>Materials and methods</h4>Clinical data of 118 patients underwent right-lobe AALDLT from January 2004 to December 2011 were retrospectively analyzed, Patients were divided into Group L (MELD score ≤ 25) and Group H (MELD score > 25) according to MELD score. The patients were further stratified into Group LS (MELD score ≤ 25, GBWR < 0.8%), Group LN (MELD score ≤ 25, GBWR ≥ 0.8%), Group HS (MELD score > 25, GBWR < 0.8%), and Group HN (MELD score > 25, GBWR ≥ 0.8%) to investigate the impact of graft size on recipients' complications and outcomes. Pre-operative characteristics, post-operative complications graded by the Clavien score and patient survival were analyzed.<h4>Results</h4>MELD scores between the two groups were significant different (12.4 ± 4.9 vs 34.5 ± 7.5, P = 0.026). There was no significant difference in preoperative demographic data as well as postoperative liver function. Complication rate, length of ICU and hospital stay, graft loss, and mortality were similar in both groups. The 1- and 3- year survival were similar between group H and group L. When recipients were further stratified into group LS, LN, HS, and HN, no significant difference was found among groups in 1- and 3- year survival rate. In multivariate analysis, HCC was not a predictor for long term survival.<h4>Conclusion</h4>Our single institution experience demonstrates that it is safe to use SFSGs in high pre-MELD score recipients with the improvement of intensive care and the selection of listing criteria.
format article
author HongYu Li
Bo Li
YongGang Wei
LvNan Yan
TianFu Wen
MingQing Xu
WenTao Wang
JiaYin Yang
author_facet HongYu Li
Bo Li
YongGang Wei
LvNan Yan
TianFu Wen
MingQing Xu
WenTao Wang
JiaYin Yang
author_sort HongYu Li
title Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
title_short Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
title_full Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
title_fullStr Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
title_full_unstemmed Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
title_sort outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f310d2aabcb845a1a14ccd9b3b9687ad
work_keys_str_mv AT hongyuli outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT boli outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT yonggangwei outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT lvnanyan outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT tianfuwen outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT mingqingxu outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT wentaowang outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
AT jiayinyang outcomeofusingsmallforsizegraftsinlivingdonorlivertransplantationrecipientswithhighmodelforendstageliverdiseasescoresasinglecenterexperience
_version_ 1718421178087899136